AbbVie to acquire Apogee Therapeutics in $10.9bn deal PMLiVE 26m Biotech Pharma Apogee Therapeutics All sources
AbbVie (ABBV) stock sinks as market gains: What you should know Zacks 5d S&P 500 Markets Stock Market
AbbVie Inc. (ABBV) is a trending stock: Facts to know before betting on it Zacks 6d AbbVie Inc Pharma
Pfizer's Seagen-derived ADC pipeline suffers a setback pharmaphorum 2h Lung Cancer Pfizer Mergers and Acquisitions
Upadacitinib effective in refractory perianal Crohn’s disease, real-world data shows Hospital Pharmacy Europe 3h Inflammatory Bowel Disease
